Celularity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.About CELU
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon
CEORobert Joseph Hariri Gordon
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
CELU Key Statistics
Market cap35.33M
Market cap35.33M
Price-Earnings ratio-0.38
Price-Earnings ratio-0.38
Dividend yield—
Dividend yield—
Average volume97.49K
Average volume97.49K
High today$1.23
High today$1.23
Low today$1.21
Low today$1.21
Open price$1.23
Open price$1.23
Volume8.70K
Volume8.70K
52 Week high$4.35
52 Week high$4.35
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
As of today, Celularity(CELU) shares are valued at $1.23. The company's market cap stands at 35.33M, with a P/E ratio of -0.38.
On 2026-01-07, Celularity(CELU) stock moved within a range of $1.21 to $1.23. With shares now at $1.23, the stock is trading +1.2% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 8.7K, compared to an average daily volume of 97.49K.
Over the past 52 weeks, Celularity(CELU) stock has traded between a high of $4.35 and a low of $1.00.
Over the past 52 weeks, Celularity(CELU) stock has traded between a high of $4.35 and a low of $1.00.
People also own
Based on the portfolios of people who own CELU. This list is generated using Robinhood data, and it’s not a recommendation.